vs
Side-by-side financial comparison of INSEEGO CORP. (INSG) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $48.4M, roughly 1.6× INSEEGO CORP.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.6%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $11.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 13.6%).
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
INSG vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $75.5M |
| Net Profit | $469.0K | — |
| Gross Margin | 42.2% | 69.3% |
| Operating Margin | 2.7% | 22.7% |
| Net Margin | 1.0% | — |
| Revenue YoY | 0.6% | 27.7% |
| Net Profit YoY | 182.9% | — |
| EPS (diluted) | $-0.02 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $75.5M | ||
| Q3 25 | $45.9M | $54.5M | ||
| Q2 25 | $40.2M | $52.4M | ||
| Q1 25 | $31.7M | $46.0M | ||
| Q4 24 | $48.1M | $59.1M | ||
| Q3 24 | $54.0M | $80.5M | ||
| Q2 24 | $51.6M | $47.1M | ||
| Q1 24 | $37.5M | $43.8M |
| Q4 25 | $469.0K | — | ||
| Q3 25 | $1.4M | $8.8M | ||
| Q2 25 | $507.0K | $5.9M | ||
| Q1 25 | $-1.6M | $3.0M | ||
| Q4 24 | $-566.0K | — | ||
| Q3 24 | $9.0M | $20.3M | ||
| Q2 24 | $624.0K | $-4.5M | ||
| Q1 24 | $-4.5M | $-4.8M |
| Q4 25 | 42.2% | 69.3% | ||
| Q3 25 | 41.6% | 77.7% | ||
| Q2 25 | 41.1% | 76.5% | ||
| Q1 25 | 47.3% | 77.1% | ||
| Q4 24 | 37.3% | 76.4% | ||
| Q3 24 | 34.8% | 63.9% | ||
| Q2 24 | 36.4% | 77.4% | ||
| Q1 24 | 35.3% | 75.5% |
| Q4 25 | 2.7% | 22.7% | ||
| Q3 25 | 4.7% | 17.6% | ||
| Q2 25 | 3.2% | 12.7% | ||
| Q1 25 | -1.3% | 8.7% | ||
| Q4 24 | 3.7% | 22.6% | ||
| Q3 24 | 1.9% | 27.4% | ||
| Q2 24 | 3.6% | -4.6% | ||
| Q1 24 | -7.9% | -5.3% |
| Q4 25 | 1.0% | — | ||
| Q3 25 | 3.1% | 16.2% | ||
| Q2 25 | 1.3% | 11.2% | ||
| Q1 25 | -5.0% | 6.5% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 16.6% | 25.2% | ||
| Q2 24 | 1.2% | -9.6% | ||
| Q1 24 | -11.9% | -11.0% |
| Q4 25 | $-0.02 | $0.26 | ||
| Q3 25 | $0.03 | $0.17 | ||
| Q2 25 | $-0.03 | $0.12 | ||
| Q1 25 | $-0.16 | $0.06 | ||
| Q4 24 | $0.62 | $0.40 | ||
| Q3 24 | $-0.06 | $0.41 | ||
| Q2 24 | $-0.02 | $-0.09 | ||
| Q1 24 | $-0.44 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $-4.0M | $130.3M |
| Total Assets | $93.8M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $97.5M | ||
| Q3 25 | $14.6M | $94.4M | ||
| Q2 25 | $13.2M | $96.0M | ||
| Q1 25 | $35.1M | $93.2M | ||
| Q4 24 | $39.6M | $101.0M | ||
| Q3 24 | $12.0M | $96.7M | ||
| Q2 24 | $49.0M | $96.8M | ||
| Q1 24 | $12.3M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $-4.0M | $130.3M | ||
| Q3 25 | $-7.7M | $115.3M | ||
| Q2 25 | $-10.5M | $104.7M | ||
| Q1 25 | $-13.0M | $97.1M | ||
| Q4 24 | $-12.9M | $92.1M | ||
| Q3 24 | $-85.1M | $71.1M | ||
| Q2 24 | $-101.8M | $48.5M | ||
| Q1 24 | $-105.6M | $51.0M |
| Q4 25 | $93.8M | $216.3M | ||
| Q3 25 | $85.8M | $202.9M | ||
| Q2 25 | $83.1M | $194.9M | ||
| Q1 25 | $93.0M | $196.2M | ||
| Q4 24 | $100.0M | $213.3M | ||
| Q3 24 | $113.4M | $220.7M | ||
| Q2 24 | $149.6M | $205.0M | ||
| Q1 24 | $122.1M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.0M | $14.4M |
| Free Cash FlowOCF − Capex | $11.6M | $14.4M |
| FCF MarginFCF / Revenue | 24.0% | 19.1% |
| Capex IntensityCapex / Revenue | 0.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 25.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.5M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.0M | $14.4M | ||
| Q3 25 | $3.2M | $9.7M | ||
| Q2 25 | $-4.5M | $14.1M | ||
| Q1 25 | $-3.5M | $3.6M | ||
| Q4 24 | $-14.2M | $15.6M | ||
| Q3 24 | $14.8M | $11.0M | ||
| Q2 24 | $27.6M | $1.0M | ||
| Q1 24 | $5.2M | $11.2M |
| Q4 25 | $11.6M | $14.4M | ||
| Q3 25 | $3.1M | $9.7M | ||
| Q2 25 | $-4.7M | $14.1M | ||
| Q1 25 | $-3.5M | $3.6M | ||
| Q4 24 | $-14.3M | $15.6M | ||
| Q3 24 | $14.8M | $11.0M | ||
| Q2 24 | $27.6M | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | 24.0% | 19.1% | ||
| Q3 25 | 6.7% | 17.7% | ||
| Q2 25 | -11.6% | 26.8% | ||
| Q1 25 | -11.0% | 7.7% | ||
| Q4 24 | -29.7% | 26.4% | ||
| Q3 24 | 27.4% | 13.7% | ||
| Q2 24 | 53.5% | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
| Q4 25 | 25.50× | — | ||
| Q3 25 | 2.22× | 1.10× | ||
| Q2 25 | -8.81× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | 0.54× | ||
| Q2 24 | 44.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
